Lung cancer is a significant health concern in China, and its high incidence and mortality rates necessitate effective treatment strategies. Traditional treatments, including surgical resection, radiotherapy, and chemotherapy, have their limitations and often come with unwanted side effects. More recently, targeted therapies and immunotherapies have emerged, but they still face challenges